Dalton Transactions
Paper
C25H26N2O (370.49), C 81.05, H 7.07, N 7.56; found, C 81.29,
(Rp,S,RRu)-{(η6-p-cymene)Ru[4,5-dihydro-2-(4′-methyl[2]-
H 7.12, N 7.41. IR (CDCl3) νmax/cm−1 3031–3009, 2930, 1712, paracyclo[2](5′,8′)quinolinophane-2′-yl)-4-phenyloxazole]Cl}+BPh4
−
1
1418, 1364, 1234, 903. H NMR δ 7.95 (s, 1 H), 6.94–6.83 (four [(Rp,S,RRu)-7a] (79%): [α]2D0 = +514 (c = 0.081, CHCl3); elemental
peaks, AB system, JAB = 7.2, 2 H), 6.52 (split tight AB system, analysis: calc. for C63H60BClN2ORu (1008.50), C 75.03, H 6.00,
JAB = 7.9, 4J = 1.5, 2 H), 5.77 (dd, J = 7.7 and 1.3, 1 H), 5.51 (dd, N 2.78; found, C 74.92, H 6.05, N 2.85. 1H NMR (CD2Cl2) δ 7.90
J = 7.7 and 1.3, 1 H), 4.4 (m, 1 H), 4.34–4.29 (four peaks, AB (s, 1 H), 7. 7 (m, 3 H), 7.6 (m, 2 H), 7.3 (broad m, 8 H),
system, JAB = 8.1, 2 H), 3.87 (dd, J = 14 and 9.0, 1 H), 3.26–3.15 7.29–7.16 (four peaks, AB system, JAB = 7.5, 2 H), 7.05 (t, J = 7.4,
(m, 2 H), 3.08–2.98 (m, 3 H), 2.76 (s, 3 H), 2.59 (dt, J = 13 and 8 H), 6.90 (t, J = 7.2, 4 H), 6.79–6.63 (split AB system, JAB = 8.0,
9.0, 1 H), 1.53 (s, 3 H), 1.46 (s, 3 H); 13C NMR: δ 162.2, 150.0, 4J = 1.8, 2 H), 5.62 (dd, J = 7.8 and 1.8, 1 H), 5.59 (dd, J = 7.2
143.6, 143.4, 140.5, 139.7, 137.8, 136.7, 135.1, 132.6, 132.4, and 1.8, 1 H), 5.46 (dd, J = 7.8 and 1.8, 1 H), 5.42 (dd, J = 10
130.9, 130.6, 128.9, 128.4, 122.6, 79.5, 67.7, 37.7, 35.2, 34.5, and 9.3, 1 H), 5.05 (t, J = 8.5, 1 H), 4.06 (dd, J = 14 and 9.0,
31.8, 28.4, 28.2, 22.3.
1 H), 3.40 (dd, J = 12 and 9.7, 1 H), 3.30–3.08 (m, 3 H), 3.07
(s, 3 H), 2.96 (ddd, J = 14, 11 and 3.8, 1 H), 2.87 (dt, J = 13
and 8.9, 1 H), 2.25 (very broad s, 1 H), 1.56 (s, 3 H), 0.9–0.12
General procedure to prepare [(η6-p-cymene)Ru(QUIPHANOX)Cl]+-
B(C6H5)4− (6a, 7a, 8, 9, 10) and [(η6-p-cymene)-
(very broad
6 H), the aromatic proton absorptions of
Ru(QUIPHANOX)Cl]+PF6− complexes (6b, 7b)11
η6-p-cymene, δ 4.00 and 6.00, are very broad and hardly
The suitable quinolinophaneoxazoline ligand (QUIPHANOX) perceptible.
was stirred into dichloro(p-cymene)ruthenium(II) dimer in
(Rp,S,RRu)-{(η6-p-cymene)Ru[4,5-dihydro-2-(4′-methyl[2]-
methanol at 25 °C and the mixture was allowed to react for paracyclo[2](5′,8′)quinolinophane-2′-yl)-4-phenyloxazole]Cl}+PF6
−
2.5 h before either sodium tetraphenylborate or ammonium [(Rp,S,RRu)-7b]
(83%):
elemental
analysis,
calc.
for
hexafluorophosphate was added. After 15 min, the resulting C39H40ClF6N2OPRu (834.23), C 56.15, H 4.83, N 3.36; found,
red precipitate was filtered and washed with hexane (3 × C 56.35, H 4.61, N 3.42. 1H NMR δ 8.12 (s, 1 H), 8.00–7.50
10 mL). Crystallization from dichloromethane–diethyl ether (broad, 5 H), 7.87 (very broad s, 2 H), 7.64 (broad m, 2 H), 7.58
mixture and then from dichloromethane afforded the pure (q, J = 7.3, 1 H), 7.25–7.09 (four peaks, AB system, JAB = 7.3, 2 H),
ruthenium complex salt in 78–89% yield. Earlier, the complex 6.72–6.59 (split AB system, JAB = 7.8, 4J = 1.6, 2 H), 5.59–5.47 (m,
salts had been kept at 40 °C/0.2 mmHg for 4 h and then 4 H), 5.36 (dd, J = 10 and 9.0, 1 H), 5.16 (t, J = 9.9, 1 H), 4.09 (dd,
characterized as follows:
J = 15 and 9.4, 1 H), 3.35 (dd, J = 13 and 9.8, 1 H), 3.24–3.12
(Rp,R,RRu)-{(η6-p-cymene)Ru[4,5-dihydro-2-(4′-methyl[2]-para- (m, 3 H), 3.09 (s, 3 H), 2.97–2.90 (m, 1 H), 2.84 (dt, J = 13
−
cyclo[2](5′,8′)quinolinophane-2′-yl)-4-phenyloxazole]Cl}+BPh4
and 8.9, 1 H), 1.87 (very broad s, 3 H), the aromatic proton
[(Rp,R,RRu)-6a], (80%): [α]2D0 = +298 (c = 0.098, CHCl3); elemen- absorptions of η6-p-cymene, δ 4.00 and 6.00, are very broad and
tal analysis, calc. for C63H60BClN2ORu (1008.50), C 75.03, hardly perceptible.
1
H 6.00, N 2.78; found, C 74.96, H 6.11, N 2.82. H NMR δ 7.84
(Rp,R,RRu)-{(η6-p-cymene)Ru[4,5-dihydro-2-(4′-methyl[2]-
(s, 1 H), 7.47–7.39 (m, 13 H), 7.17–7.06 (four peaks, AB system, paracyclo[2](5′,8′)quinolinophane-2′-yl)-4-isopropyloxazole]Cl}+BPh4
JAB = 7.4, 2 H), 7.03–7.00 (m, 8 H), 6.91–6.88 (m, 4 H), [(Rp,R,RRu)-8] (89%): [α]2D0 = +221 (c = 0.069, CHCl3); elemental
6.75–6.60 (four peaks, AB system, JAB = 7.8, 2 H), 5.59 (ddd, J = analysis, calc. for C60H62BClN2ORu (974.48), C 73.95, H 6.41,
14, 10 and 3.5, 1 H), 5.55 (s, 2 H), 5.22 (t, J = 11, 1 H), 5.05 N 2.87; found, C 73.88, H 6.50, N 2.95. 1H NMR δ 7.73 (s, 1 H),
(broad s, 2 H), 4.92 (t, J = 9.5, 1 H), 4.82 (broad d, J = 5.5, 1 H), 7.38 (broad s, 8 H), 7.11 (d, JAB = 7.4, 1 H), 7.01 (t, J = 7.2, 9 H),
4.77 (broad d, J = 5.3, 1 H), 4.47 (dd, J = 11 and 9.3, 1 H), 6.91 (t, J = 7.2, 4 H), 6.72–6.58 (split AB system, J = 7.9, 4J = 1.6, 2 H),
−
4.00 (dd, J = 15 and 9.0, 1 H), 3.34 (dd, J = 12 and 9.7, 1 H), 5.56 (ddd, J = 14, 11 and 3.4, 1 H), 5.51–5.44 (split AB system, JAB
3.1 (m, 2 H), 3.12–3.05 (m, 1 H), 3.02 (s, 3 H), 2.8 (m, 2 H), 1.5 7.9, 4J = 1.8, 2 H), 5.12 (d, J = 5.9, 1 H), 4.90–4.85 (AB system, JAB
=
=
(bs, J = 6.7, 1 H), 1.00 (very broad s, 3 H), 0.45 (very broad s, 5.9, 2 H), 4.79 (d, J = 6.0, 1 H), 4.65 (dd, J = 9.2 and 5.9, 1 H), 4.50
3 H), 0.43 (d, J = 6.9, 3 H).
(t, J = 9.8, 1 H), 4.23 (ddd, J = 9.7, 5.8 and 2.7, 1 H), 4.01 (dd, J =
(Rp,R,RRu)-{(η6-p-cymene)Ru[4,5-dihydro-2-(4′-methyl[2]- 15 and 8.9, 1 H), 3.35 (dd, J = 13 and 9.8, 1 H), 3.22–3.04 (m, 3 H),
−
paracyclo[2](5′,8′)quinolinophane-2′-yl)-4-phenyloxazole]Cl}+PF6
3.01 (s, 3 H), 2.89 (ddd, J = 14, 11 and 3.4, 1 H), 2.79 (dt, J = 13
[(Rp,R,RRu)-6b],
84%:
elemental
analysis,
calc.
for and 9.1, 1 H), 2.37 (sept d, J = 7.0 and 2.4, 1 H), 2.02 (broad sept,
C39H40ClF6N2OPRu (834.23), C 56.15, H 4.83, N 3.36; found, J = 6.7, 1 H), 1.18 (s, 3 H), 1.07 (d, J = 7.2, 3 H), 0.90 (d, J = 6.5,
C 56.19, H 4.94, N 3.42. 1H NMR: δ 7.90 (s, 1 H), 7.73 (d, J = 6.9, 3 H), 0.88 (d, J = 6.9, 3 H), 0.69 (d, J = 6.9, 3 H).
2 H), 7.5 (m, 3 H), 7.23–7.08 (four peaks, AB system, JAB = 7.4, 2
(Rp,S,RRu)-{(η6-p-cymene)Ru[4,5-dihydro-2-(4′-methyl[2]-para-
4
−
H), 6.76–6.62 (split AB system, JAB = 8.0, and J = 1.2, 2 H), 6.30 cyclo[2](5′,8′)quinolinophane-2′-yl)-4-isopropyloxazole]Cl}+BPh4
(t, J = 11, 1 H), 5.79 (d, J = 6.0, 1 H), 5.73 (d, J = 6.0, 1 H), [(Rp,S,RRu)-9] (85%): [α]D20
= +575 (c = 0.105, CHCl3);
5.66–5.57 (m, 3 H), 5.49 (d, J = 6.1, 1 H), 5.25 (d, J = 5.9, 1 H), elemental analysis, calc. for C60H62BClN2ORu (974.48),
5.13 (d, J = 5.9, 1 H), 4.73 (dd, J = 11 and 8.5, 1 H), 4.09 (dd, J = C 73.95, H 6.41, N 2.87; found, C 74.18, H 6.48, N 2.95. 1H
14 and 9.1, 1 H), 3.38 (dd, J = 13 and 10, 1 H), 3.33–3.14 (m, 3 NMR: δ 7.59 (s, 1 H), 7.4 (broad m, 8 H), 7.13–7.04 (four peaks,
H), 3.09 (s, 3 H), 2.95–2.89 (m, 1 H) 2.87 (dt, J = 13 and 9.6, 1 H), AB system, JAB, 7.4, 2 H), 7.00 (t, J = 7.2, 8 H), 6.89 (t, J = 7.1,
1.73, (very broad s, 1 H), 1.25 (very broad s, 3 H), 0.56 (very 4 H), 6.60–6.58 (split AB system, JAB = 7.9, 4J = 1.7, 2 H),
broad s, 3 H), 0.51 (d, J = 6.8, 3.42).
5.49–5.38 (split AB system, JAB = 7.9, 4J = 1.8, 2 H), 5.28–5.22
This journal is © The Royal Society of Chemistry 2014
Dalton Trans., 2014, 43, 1636–1650 | 1647